VanEck Biotech ETF (BBH)
| 144.33 BATS BZX Real-Time Price As of 10:20am ET |  +1.46 / +1.02%Today’s Change | 133.45 Today|||52-Week Range 222.22 | -23.77% Year-to-Date |
Investment Objective
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS ® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Latest BBH News
| Should You Invest in the VanEck Biotech ETF (BBH)? May 16 / Zacks.com - Paid Partner Content | How Are Biotech ETFs Reacting to These Q1 Earnings Releases? May 10 / Zacks.com - Paid Partner Content |
Performance
| 1 month | -10.91% | 3 years | +7.15% | |
| 3 months | -5.73% | 5 years | +4.97% | |
| 1 year | -17.58% | Since inception | +14.97% |
Data through 05/18/2022
Quote Details
| Previous close | $142.87 |
| Open day’s range | 144.33 – 144.33 |
| Net asset value (NAV) | 143.12 (05/18/2022) |
| Daily volume | 80 |
| Average volume (3 months) | 25,114 |
Data as of 10:20am ET, 05/19/2022
Peer Comparisonvs. Health ETFs
| BBH | Category | |
|---|---|---|
| Performance 5-yr return | +4.97% | +11.31% |
| Expense Gross exp ratio | 0.35% | 1.00% |
| Risk 5 year sharpe ratio | 0.24 | 0.52 |
| Net assets | $439.0M | $1.9B |
| Average market cap | $38.3B | $41.8B |
| Average P/E | 14.7 | 25.8 |
| Dividend / Share | -- | 0.26% |
Competitors
| IEHS iShares Evolved U.S. Healthcare Staples ... |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
Top 10 HoldingsPortfolio weighting
| AMGN Amgen | 13.88% |
| VRTX Vertex Pharmaceuticals Inc | 7.84% |
| GILD Gilead Sciences | 7.30% |
| REGN Regeneron Pharmaceuticals | 6.90% |
| MRNA Moderna Inc | 6.58% |
| IQV IQVIA Holdings Inc | 5.17% |
| ILMN Illumina Inc | 4.91% |
| BIIB Biogen | 4.80% |
| BNTX BioNTech SE | 4.29% |
| TECH Bio-Techne Corp | 4.12% |
